LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Statistics

Total Valuation

LVTX has a market cap or net worth of $48.39 million. The enterprise value is -$32.25 million.

Market Cap	48.39M
Enterprise Value	-32.25M

Important Dates

The next estimated earnings date is Monday, November 18, 2024, before market open.

Earnings Date	Nov 18, 2024
Ex-Dividend Date	n/a

Share Statistics

LVTX has 26.30 million shares outstanding. The number of shares has increased by 3.10% in one year.

Current Share Class	26.30M
Shares Outstanding	26.30M
Shares Change (YoY)	+3.10%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	7.17%
Float	12.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.71
Forward PS	n/a
PB Ratio	1.13
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.39, with a Debt / Equity ratio of 0.14.

Current Ratio	6.39
Quick Ratio	6.23
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -45.30% and return on invested capital (ROIC) is -28.65%.

Return on Equity (ROE)	-45.30%
Return on Assets (ROA)	-15.99%
Return on Capital (ROIC)	-28.65%
Revenue Per Employee	$199,946
Profits Per Employee	-$653,595
Employee Count	37
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, LVTX has paid $265,000 in taxes.

Income Tax	265,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.27% in the last 52 weeks. The beta is 0.48, so LVTX's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+57.27%
50-Day Moving Average	1.73
200-Day Moving Average	2.20
Relative Strength Index (RSI)	52.08
Average Volume (20 Days)	70,095

Short Selling Information

The latest short interest is 2,426, so 0.01% of the outstanding shares have been sold short.

Short Interest	2,426
Short Previous Month	9,747
Short % of Shares Out	0.01%
Short % of Float	0.02%
Short Ratio (days to cover)	0.07

Income Statement

In the last 12 months, LVTX had revenue of $7.40 million and -$24.18 million in losses. Loss per share was -$0.90.

Revenue	7.40M
Gross Profit	7.23M
Operating Income	-27.48M
Pretax Income	-28.31M
Net Income	-24.18M
EBITDA	-26.88M
EBIT	-27.48M
Loss Per Share	-$0.90

Balance Sheet

The company has $86.80 million in cash and $6.16 million in debt, giving a net cash position of $80.64 million or $3.07 per share.

Cash & Cash Equivalents	86.80M
Total Debt	6.16M
Net Cash	80.64M
Net Cash Per Share	$3.07
Equity (Book Value)	42.88M
Book Value Per Share	1.63
Working Capital	76.06M

Cash Flow

In the last 12 months, operating cash flow was -$27.08 million and capital expenditures -$6,000, giving a free cash flow of -$27.09 million.

Operating Cash Flow	-27.08M
Capital Expenditures	-6,000
Free Cash Flow	-27.09M
FCF Per Share	-$1.03

Margins

Gross Margin	97.78%
Operating Margin	-371.48%
Pretax Margin	-323.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-254.47%

Dividends & Yields

LVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.10%
Shareholder Yield	-3.10%
Earnings Yield	-49.98%
FCF Yield	-55.98%

Analyst Forecast

The average price target for LVTX is $6.00, which is 226.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	226.09%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	42.46%
EPS Growth Forecast (5Y)	-6.70%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LVTX has an Altman Z-Score of -1.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.65
Piotroski F-Score	2